The Official Publication Of The Florida Pharmacy Association FEB. 2021
CONTROLLED SUBSTANCE DISPENSING IN FLORIDA DURING COVID-19
IMPROVE
YOUR PHARMACY OPERATIONS • Minimize dispensing errors • Increase revenue and profitability • Automate workflow management • Customize analytics and reports
Pharmacy Management System
Schedule a DEMO today!
(866) 495-3999
sales@micromerchantsystems.com
www.micromerchantsystems.com
Web portals and apps for patients, physicians and owners Turnkey refill management and automation RxSync – sync all refills to one date Two-way SMS/text message from the patient’s profile Route optimization through Google Maps Customizable workflow capabilities for Specialty, Mail Order and other pharmacy configurations Clinical assessment module
florida PHARMACY TODAY
VOL. 84 | NO. 2 FEBRUARY 2021 THE OFFICIAL PUBLICATION OF THE FLORIDA PHARMACY ASSOCIATION
Features
Departments 4 Calendar 4 Advertisers 5 Executive Insight 6 Call for Resolutions
8 12 14 16 18
Controlled Substance Dispensing in Florida During COVID-19 Bacteria Can Be Good for You! FPA 131st Annual Meeting and Convention FPA Legislative Highlights — March
Nominations for FPA Awards
REPRESENTING PHARMACISTS The Florida Pharmacy Association is pleased to share with the membership that FPA member and Florida panhandle pharmacist Shane Abbott has declared his intent to run for House District 5 which includes Holmes, Jackson, Walton and parts of Bay counties. Shane is the co-owner of The Prescription Place in Defuniak Springs and is a graduate of Pensacola Junior College and the University of Florida College of Pharmacy. Members who wish to make a contribution may go to voteshaneabbott.com. Paid electioneering communication paid for in kind by the Florida Pharmacy Association, 610 North Adams Street, Tallahassee, Florida 32301
FEBRUARY 2021
|
3
Mission Statements:
FPA Calendar 2020
MARCH 2
MAY
Legislative Session Begins
12-15 APhA Annual Meeting Virtual 20-21 FPA Council meetings TBD
9
15-16 Clinical Conference JUNE 8
Last day to submit items of new business to the House of Delegates
8
Last day to register for the House of Delegates summer session
APRIL 2
Good Friday, FPA office closed
17-18 FPA Regulatory and Law conference 30
Last day to submit resolutions to the House of Delegates
Last day of the Legislative session
Events calendar subject to change
CE CREDITS (CE cycle) The Florida Board of Pharmacy requires 10 hours’ LIVE continuing education as part of the required 30 hours’ general education needed every license renewal period. There is a two-hour CE requirement for pharmacists on the dispensing of controlled substances effective this biennial renewal period. Pharmacists and pharmacy technicians must also have completed a one-hour Florida Board approved continuing education on human trafficking by Jan. 1, 2021. Pharmacists should have satisfied all continuing education requirements for this biennial period by Sept. 30, 2021, or prior to licensure renewal. Consultant pharmacists and technicians will need to renew their licenses and registrations by Dec. 31, 2022. For the Pharmacy Technician Certification Board application, exam information and study materials, please contact the FPA office. For more information on CE programs or events, please contact the Florida Pharmacy Association at (850) 222-2400 or visit our website at www.floridapharmacy.org CONTACTS FSHP — Tamekia Bennett (850) 906-9333 UF — Emely McKitrick (352) 273-5169
FAMU — Leola Cleveland (850) 599-3301 NSU — Carsten Evans (954) 262-1300
The Florida Pharmacy Today Journal is a peer-reviewed journal which serves as a medium through which the Florida Pharmacy Association can communicate with the profession on advances in the sciences of pharmacy, socio-economic issues bearing on pharmacy and newsworthy items of interest to the profession. As a self-supported journal, it solicits and accepts advertising congruent with its expressed mission.
Florida Pharmacy Today Board of Directors
FOR A COMPLETE CALENDAR OF EVENTS GO TO WWW.FLORIDAPHARMACY.ORG
FPA — Michael Jackson (850) 222-2400
Florida Pharmacy Today Journal
Note: The views of the authors do not necessarily represent the views or opinions of the Florida Pharmacy Association, Florida Pharmacy Today or any related entities.
The mission of the Florida Pharmacy Today Board of Directors is to serve in an advisory capacity to the managing editor and executive editor of the Florida Pharmacy Today Journal in the establishment and interpretation of the Journal’s policies and the management of the Journal’s fiscal responsibilities. The Board of Directors also serves to motivate the Florida Pharmacy Association members to secure appropriate advertising to assist the Journal in its goal of self-support.
Advertisers APMS..................................................................... 8 BOWL OF HYGEIA............................................ 13 EPIC..................................................................... 11 MICRO MERCHANTS........................................ 2 PQC...................................................................... 20 PHARMACISTS MUTUAL.............................. 17
DISCLAIMER Articles in this publication are designed to provide accurate and authoritative information with respect to the subject matter covered. This information is provided with the understanding that neither Florida Pharmacy Today nor the Florida Pharmacy Association is engaged in rendering legal or other professional services through this publication. If expert assistance or legal advice is required, the services of a competent professional should be sought. The use of all medications or other pharmaceutical products should be used according to the recommendations of the manufacturers. Information provided by the maker of the product should always be consulted before use.
4 |
FLORIDA PHARMACY TODAY
EMAIL YOUR SUGGESTIONS/IDEAS TO dave@fiorecommunications.com
Executive Insight BY MICHAEL JACKSON, RPH MICHAEL JACKSON, BPHARM, EVP & CEO, FLORIDA PHARMACY ASSOCIATION
Changes in Public Policy and Donations to Political Committees: The Relationship Is Real
A
s a profession, there are all kinds of tools available to advocate for and influence good public policy making. Generally, the issues that the Florida Pharmacy Association will bring to the table have been beneficial to improving public health, lowering costs and also growing professional opportunities for our industry. The tools we use to get these issues on the table are driven by our comprehensive advocacy efforts of our Governmental Affairs Committee, FPA leadership, volunteer members, lobbyists and general counsel. There are many hours devoted to building a viable plan designed to convince the 120 members of the Florida House and 40 members of the Florida Senate that our suggestions are worthy of debate. This includes the development of draft language, talking points, and hosting informational webinars and countless hours meeting and educating members of the Florida Legislature. In some cases the issues are so complex that we also need to facilitate informational meetings within our own stakeholder group so that everyone can understand what is being done and why. It would be ideal if doing the things mentioned above would be all that was needed, however there is one more very important tool the FPA needs to be successful in an aggressive advocacy campaign. We have to elect members of the House and Senate who understand our profession and are sensitive to our needs. To do that we have to invest heavily in political campaigns using the resources we have in the Florida Pharmacist Political Committee.
What is the Florida Pharmacist Political Committee? The Florida Pharmacist Political Committee (FPPC) is a voluntary nonprofit organization of pharmacists and others created to promote and strive for the improvement of state policy decision making that affects the practice and business of pharmacy. It is one of the most effective ways to help the profession achieve its legislative agenda through coordinated support of political campaigns and issues friendly to our cause. The funding for the FPPC comes solely from member and corporate donations. Over 90 percent of the donations you make go toward political campaigns recommended by our lobbyists as beneficial investments. These recommended donations are reviewed and approved by the FPPC Board of Directors consisting of volunteer FPA members. The only costs of the FPPC are mandatory state reporting, accounting and recordkeeping requirements. None of these resources are used by the FPA. Our investments through the FPPC has resulted in a number of pharmacyproactive issues being signed into law by Florida’s governors. We also have development-friendly legislative advocates who are fighting off some of the bad issues that we see proposed from time to time. This message to our members in this issue of Florida Pharmacy Today is critical in that we need to rebuild the FPPC war chest and ask that you consider making a donation to the FPPC. We are accepting, Mastercard, Visa, Discover as well as American Express. You may also donate by check. There is even an option for you to make reg-
Michael Jackson, B.Pharm
ular monthly automated donations if you choose to do so. We want to thank our many long-term supporting members including John Noreiga, William Garst, Theresa Tolle, Barbara Beadle, Kathy Petsos, Preston McDonald, Norman Tomaka, Howard Kichler, Alex Pytlarz and many others who are regularly making generous donations. To view a complete list of donors visit this hyperlink: https://dos.elections.myflorida.com/committees/ComDetail. asp?account=60881 The FPPC needs your support and we hope that you will add your name to our growing list of donors. Please join me in helping support our profession. In looking at our member database, we have about 5 percent of our members who are donating to the FPPC. It would be amazing if we can get that percentage above 25 percent. It could make a difference in good or bad public policy making. n FEBRUARY 2021
|
5
FPA STAFF Executive Vice President/CEO Michael Jackson (850) 222-2400, ext. 200
Director of Continuing Education Tian Merren-Owens, ext. 120
Continuing Education Coordinator Stacey Brooks, ext. 210 Coordinator of Membership Christopher Heil, ext. 110
FLORIDA PHARMACY TODAY BOARD Chair............................... Carol Motycka, St. Augustine Vice Chair.........................Cristina Medina, Hollywood Treasurer.................................... Eric Jakab, Gainesville Secretary............................. Julie Burger, Pensacola Member.........................Michael Finnick, Jacksonville Member.............David Mackarey, Boynton Beach Member....................................... Matt Schneller, Tampa Member............................Teresa Tomerlin, Rockledge Member...................................... Greta Pelegrin, Hialeah Technician Member..........Julie Burger, Pensacola Executive Editor.......Michael Jackson, Tallahassee Managing Editor...................Dave Fiore, Tallahassee Journal Reviewer........................... Dr. Melissa Ruble Journal Reviewer....................................Dr. Angela Hill This is a peer-reviewed publication. . ©2021 FLORIDA PHARMACY JOURNAL, INC. ARTICLE ACCEPTANCE: The Florida Pharmacy Today is a publication that welcomes articles that have a direct pertinence to the current practice of pharmacy. All articles are subject to review by the Publication Review Committee, editors and other outside referees. Submitted articles are received with the understanding that they are not being considered by another publication. All articles become the property of the Florida Pharmacy Today and may not be published without written permission from both the author and the Florida Pharmacy Today. The Florida Pharmacy Association assumes no responsibility for the statements and opinions made by the authors to the Florida Pharmacy Today. The Journal of the Florida Pharmacy Association does not accept for publication articles or letters concerning religion, politics or any other subject the editors/publishers deem unsuitable for the readership of this journal. In addition, The Journal does not accept advertising material from persons who are running for office in the association. The editors reserve the right to edit all materials submitted for publication. Letters and materials submitted for consideration for publication may be subject to review by the Editorial Review Board.
FLORIDA PHARMACY ASSOCIATION
610 N. Adams St. • Tallahassee, FL 32301 850/222-2400 • FAX 850/561-6758 Web address: www.floridapharmacy.org.
CALL FOR RESOLUTIONS TO THE 2021 HOUSE OF DELEGATES The House of Delegates Board of Directors will meet in May 2021 to review and approve resolutions for the Annual Meeting. The deadline for submitting resolutions is May 9, 2021! PLEASE NOTE THIS DEADLINE. The last day to submit items of new business is June 8, 2021. The following information will be needed when submitting resolutions: 1. Name of organization: The name of the organization submitting the resolutions(s); 2. Name and telephone number of individuals: A contact in the event clarification or further information is needed; 3. Problem: A statement of the problem addressed by the resolution; 4. Intent: A statement of what passage of the resolution will accomplish; 5. Resolution Format: Please type and use double spacing. TITLE OF RESOLUTION NAME OF ORGANIZATION WHEREAS , AND
WHEREAS :
THEREFORE BE IT RESOLVED (THAT THE FPA OR SUBDIVISION OF FPA)
CONTACT NAME AND PHONE #: PROBLEM: INTENT:
Return this form to: Membership Coordinator, Florida Pharmacy Association, 610 North Adams Street, Tallahassee, Florida 32301 or fax (850) 561-6758
Protect your patients. Protect your pharmacy. ERR ORS C A N I NJ U R E PATIE NTS AND P U T YO UR PHAR M ACY I N F IN AN C IAL J EOPAR DY.
The PQC+ QA program can improve efficiency and increase patient safety as well as help you meet accreditation, credentialing, PBM and state Quality Assurance requirements. • Training, Quality Assurance CE, and resources • Patient Safety Organization protection for your QA work • Practical tools to collect and analyze patient safety data
Learn more at www.medicationsafety.org or call us at (866) 365-7472. The Alliance of Medication Safety (APMS) is a federally listed Patient Safety Organization (PSO).
Controlled Substance Dispensing in Florida During COVID-19 Authors
I. Program overview and COVID-19 impact.
Rebecca Poston, BPharm, MHL, Program Manager, Prescription Drug Monitoring Program, Rebecca.Poston@flhealth.gov
The Prescription Drug Monitoring Program (PDMP) administers the Prescription Drug Monitoring System (PDMS). The web-based system, known as E-FORCSE (Electronic Florida Online Reporting of Controlled Substances Evaluation), facilitates the collection, storage, maintenance, and analysis of controlled substance dispensing data reported by pharmacies and dispensing health care practitioners. Section 893.055(8), Florida Statutes, requires those who prescribe and dispense controlled substances to consult the patient’s controlled substance prescription history before prescribing or dispensing such substances unless a statutory exemption exists. By law, the PDMP may integrate information into an electronic health recordkeeping system (EHR) and share data with other states compatible with Florida’s system. Also, the PDMP may release confidential and exempt information in accordance with Florida law. Florida’s PDMP is an essential resource for clinicians to assess a patient’s controlled substance prescription dispensing history. While Florida has seen an increase in registration and utilization, one of the Department of Health’s (Department) primary goals is to minimize any practitioner workflow disruption by providing near-instant and seamless access to critical prescription history information at the point of care. The Department continually strives for excellence in promoting balanced use of prescription data while preserving health care providers’ professional practice and patient’s access to optimal pharmaceutical care. Florida’s response to COVID-19 began on March 1, 2020, when Governor Ron DeSantis issued Executive Order 202051, directing the State Surgeon General, who heads the Florida Department of Health, to declare a public health emergency in response to SARS-CoV2 virus, coronavirus disease 2019 (COVID-19). Florida Governor’s Executive Order established the COVID-19 Response Protocol and included other directives. Executive Order 2020-52 declared a State of Emergency for the entire state and found that COVID-19 is a severe acute respiratory illness that can spread among humans through respiratory transmission and presents with influenza-like symptoms. Executive Order 2020-91 noted that action is necessary and appropriate to slow the spread of COVID-19, ensuring residents and visitors in Florida remain safe. The following pages describe the changes identified in Florida’s PDMS during the COVID-19 pandemic. According to the most recent Florida data, pharmacists and dispensing health care practitioners dispensed 30 million controlled substance prescriptions to Florida residents during the review period. A decline in the number of schedule II opioid prescrip-
Erika Marshall, BS, Program Outreach Director, Prescription Drug Monitoring Program, Erika.Marshall@flhealth.gov Fritz Hayes, BPharm, Senior Pharmacist, Prescription Drug Monitoring Program, Carl.Hayes@flhealth.gov Kelli Ferrell, BPharm, PhD, Senior Pharmacist, Prescription Drug Monitoring Program, Kelli.Ferrell@flhealth.gov Yanning Wang, MS, Data Management Analyst, Department of Health Outcomes and Biomedical Informatics, University of Florida College of Medicine,ynwang@ufl.edu
8 |
FLORIDA PHARMACY TODAY
tions dispensed resulted in an overall 6.0 percent decrease. Simultaneously, there was a sharp increase in schedule II opioid prescriptions dispensed with less than three days’ supply and a seven-day supply reduction. In contrast, morphine milligram equivalents (MMEs) decreased by 15.5 percent. As expected, PDMS consultation fell during COVID-19; however, it returned to previous levels in June 2020. II. Florida pharmacists dispensed more than 30 million controlled substance prescriptions in schedules II through V to Florida residents 18 years of age and older during the State Fiscal Year (SFY) July 1, 2019 through June 30, 2020 (Figure 1). ■
Of those 30 million prescriptions dispensed during SFY 2019-2020, almost 36 percent were for alprazolam, oxycodone short-acting, and hydrocodone short-acting. • Further data analysis illustrates dispensers dispensed: ◦ 12.9 million opioid prescriptions ◦ 9.2 million benzodiazepine prescriptions ◦ 1.9 million stimulant prescriptions
■
■
■
Data for 3.1 million Florida residents reveal an average of 4.1 opioid prescriptions, 5.0 benzodiazepine prescriptions, and 5.9 stimulant prescriptions were dispensed per patient. Some variation exists in controlled substance prescribing when patient age is taken into account. Opioid prescription dispensing rate per patient begins to decline for patients 65 and older. Benzodiazepine prescriptions per patient do not vary much for patients aged 55 and over. The number of stimulant prescriptions per patient peaks for patients 35 through 44 years. Likewise, variation in controlled substance dispensing exists across different areas of the state. Rural areas of north Florida have a higher rate of opioid dispensing per patient, while the benzodiazepine dispensing rate is highest in northwest Florida, Tampa Bay and Miami areas. Unlike opioids and benzodiazepines, patients with a higher number of stimulant prescriptions tend to be clustered in coastal counties.
Figure 1
FEBRUARY 2021
|
9
Figure 2
III. During COVID-19, prescriber PDMS consultations declined while dispenser consultations remained steady (Figure 2). ■
■
■
10
Consultation of the patient’s controlled substance prescription history is required before prescribing or dispensing a controlled substance unless a statutory exemption exists. The PDMP may integrate information into an EHR, such as those in health systems, physicians’ offices, and pharmacy management systems. Also, Florida is sharing its data with 30 other states. Consultation requests from prescribers decreased by 20 percent during the COVID-19 State of Emergency in April 2020 but returned to previous levels (6.5 million) in June 2020. This is partly due to the temporary closure of prescriber practices or writing prescriptions with a longer days’ supply. The number of schedule II opioid prescriptions with up to 7 days’ supply initially fell during the COVID-19 State of Emergency but returned to previous levels in June 2020. Dispensers consultation remained stable as pharmacies are essential businesses that stayed open during the COVID-19 State of Emergency.
|
FLORIDA PHARMACY TODAY
WHILE FLORIDA HAS SEEN AN INCREASE IN REGISTRATION AND UTILIZATION, ONE OF THE DEPARTMENT OF HEALTH’S (DEPARTMENT) PRIMARY GOALS IS TO MINIMIZE ANY PRACTITIONER WORKFLOW DISRUPTION BY PROVIDING NEARINSTANT AND SEAMLESS ACCESS TO CRITICAL PRESCRIPTION HISTORY INFORMATION AT THE POINT OF CARE.
Figure 3
IV. The decline in average daily MMEs per schedule II opioid prescription that began in 2018 due to statutory changes continued during the State of Emergency (Figure 3). ■
■
■
■ ■
The PDMP observed a substantial decline in the average daily MME per schedule II opioid prescription since Chapter 2018-13, Laws of Florida took effect on July 1, 2018. From SFY 2018-2019 to SFY 2019-2020, the daily MME continued to decline. On average, it decreased from 75.6 in SFY 2018-2019 to 63.9 in SFY 2019-2020 (-15.5 percent). Although the proportion of schedule II opioid prescriptions with longer days’ supply increased during the COVID-19 State of Emergency, the daily MME per prescription remained stable. The average daily MME per schedule II opioid prescription was highest in patients aged 55 through 64. Several north Florida counties and South Florida remain the highest concentrated daily MME amounts.
Reference
1. http://www.floridahealth.gov/statistics-and-data/e-forcse/ news-reports/2020-pdmp-annual2. report.pdf. Accessed on December 1, 2020. 3. Id. 1 4. Id. 1 5. https://www.flgov.com/wp-content/uploads/orders/2020/ EO_20-51.pdf. Accessed October 15,
Helping independent pharmacies compete since 1982. Now with more services to thrive in today's pharmacy landscape. • New! Exclusive! ERxDirect telemed platform with care management revenue opportunities • New! Consumer engagement model for better outcomes and adherence • Group volume purchasing • Profits distributed to members at year-end • EPIC Pharmacy Network – third party contracting • – claims reconciliation and automated reimbursements below cost system • – regulatory and compliance management
A Network Of Independently Owned Pharmacies 800-965-EPIC (3742) | epicrx.com membersupport@epicrx.com
FEBRUARY 2021 |
11
Bacteria Can Be Good for You! William Garst, Pharm.D., Consultant Pharmacist
Much has been written lately about antimicrobial medications. While it is true we need these medications for certain species of microbes, not all bacteria are harmful and can even convey health benefits. These products are referred to as functional foods and specifically probiotics, a term from the Greek meaning “for life.” William Garst The Food and Agriculture Organization (FAO), the World Health Organization (WHO), along with the European Food Safety Authority have agreed on the definition that a probiotic is a “live microorganism that, when administered in adequate amounts, confer a health benefit on the host.” Probiotics have been used since the Greek and Roman times in the form of fermented foods, which they used as a method of preserving food. The more modern idea of probiotics can be traced back to the turn of the 20th century to Eli Metchnikoff, who in 1907 suggested that it was possible to replace harmful gut microbes with useful ones. Metchnikoff noticed that some communities in Bulgaria lived exceptionally long lives and theorized that the main part of their diet was a fermented drink (sour milk). He believed the bacteria in the sour milk replaced the bacteria in the gut that contributed to aging. The research to date has established certain benefits of probiotics and suggested that they could help in many areas. The most research-validated positive effects of probiotic consumption have been in arresting diarrhea of different types. Acute infantile diarrhea caused by rotaviruses is treated mainly with rapid oral rehydration, but it has been found that treating patients with probiotics is a useful adjunct to therapy. Antibiotics, given to treat infections, can disrupt the natural microbial flora in the gut, and this leads to what is called antibiotic-associated diarrhea. The third type of diarrhea that probiotics have been shown to help is traveler’s diarrhea, which mainly occurs when people travel from industrialized countries to developing countries, especially tropical and subtropical regions. The research on probiotics indicates that they may help in other conditions, though more research needs to be done to support these claims. Various conditions include lactose intolerance, irritable bowel syndrome, inflammatory bowel disorder, Crohn’s disease, ulcerative colitis, and cardiovascular diseases. Probiotics may also help in treating obesity, improve immunity, metabolism of fats, the bioavailability and uptake of minerals, and reducing cancer risk, along with laxation and producing regularity. Notably, there are many dozens of bacteria strains, and some strains convey different health benefits, but it is beyond the scope of this column to review all this data. It is up to the reader to talk to their pharmacist and health care provider about probiotic use. Also, by researching the internet under 12
|
FLORIDA PHARMACY TODAY
“probiotics”, numerous websites can be found that give good information. One thing that should be kept in mind if considering using a probiotic is they are generally recognized as safe (GRAS) but should be used with caution in people who have a compromised immune system. Please consult with your health care provider if you have any condition that makes you prone to infections.
THE MORE MODERN IDEA OF PROBIOTICS CAN BE TRACED BACK TO THE TURN OF THE 20TH CENTURY TO ELI METCHNIKOFF, WHO IN 1907 SUGGESTED THAT IT WAS POSSIBLE TO REPLACE HARMFUL GUT MICROBES WITH USEFUL ONES. Probiotics usually come in doses that are called colonyforming units (CFU). From my research, a good rule of thumb would be to use doses of 10 billion CFU’s or more per dose. Usually, probiotics are refrigerated after opening, or some are refrigerated at the store. Also, be aware of expiration dates because you are dealing with live microorganisms, and it is also good to use products that have a variety of bacteria strains that are used for your purpose. Another strategy to consider is if a certain brand of probiotic does not seem to help in your condition, do not give up. There are a great many variables surrounding probiotics and another brand may have the right combination for you. Even though probiotics have been around for a long time they are becoming more prominent. Much of the research is being done by academia because most pharmaceutical companies are looking for a unique patentable molecule and microorganisms do not fit in that category. Probiotics are gaining recognition as being a healthy addition to one’s diet or supplements. Stay informed and stay healthy. William Garst is a consultant pharmacist who resides in Alachua, Florida. He received his bachelor’s degree in pharmacy from Auburn University in 1975. He earned a master’s degree in pharmacy from the University of Florida in 2001. In 2007, he received his doctor of pharmacy from the University of Colorado. Dr. Garst is a member of many national professional associations as well as the local Alachua County Association of Pharmacists. He serves on the Alachua County Health Care Advisory Board. He works part-time at the UF Health Psychiatric Hospital and retired from the VA in 2016. Dr. Garst enjoys golf, reading (especially history) and family. He writes a blog called The Pharmacy Newsletter (https://thepharmacy newsletter. com). He can be contacted at communitypharmacynewsletter@ gmail.com .
2020 Recipients of the “Bowl of Hygeia” Award
Barry Rich Alabama
Robert Kronenberg Arizona
Mike Smets Arkansas
Robert Scheidtmann California
Debra Devereaux Colorado
Mark Petruzzi Connecticut
Hooshang Shanehsaz Delaware
Humberto Martinez Florida
Drew Miller Georgia
Wendy Iwasaki Hawaii
David Mikus Illinois
Tom DeVille Indiana
Peter Fay Iowa
Mike Bellesine Kansas
Bob Oakley Kentucky
Stephen Hill Louisiana
Kevin Holland Maine
Carol Stevenson Maryland
Todd Brown Massachusetts
Carrie Germain Michigan
Kendra Metz Minnesota
Ann Franklin Mississippi
Marty Michel Missouri
Howard Beall Montana
Christopher Shaffer Nebraska
Daniel Heller Nevada
Thomas Algozzine New Hampshire
Ed Rucki New Jersey
Chris Woodul New Mexico
Amina Abubakar North Carolina
David Sandberg North Dakota
Troy Gahm Ohio
Linda Howrey Oregon
Gerard O'Hare Pennsylvania
Tracey Taveira Rhode Island
Tenny Moss South Carolina
Doug Johnson South Dakota
Roger Davis Tennessee
Takova Wallace-Gay Texas
Paige Patterick Utah
Rob Carpenter Vermont
Mark Vaughan Virginia
Don Downing Washington
Jose Diaz-Luna Washington DC
The “Bowl of Hygeia”
Photo Not Available
Roger Paganelli New York
Ron Mabie Wisconsin
Antoinette Brown Wyoming
The Bowl of Hygeia award program was originally developed by the A. H. Robins Company to recognize pharmacists across the nation for outstanding service to their communities. Selected through their respective professional pharmacy associations, each of these dedicated individuals has made uniquely personal contributions to a strong, healthy community. We offer our congratulations and thanks for their high example. The American Pharmacists Association Foundation, the National Alliance of State Pharmacy Associations and the state pharmacy associations have assumed responsibility for continuing this prestigious recognition program. All former recipients are encouraged to maintain their linkage to the Bowl of Hygeia by emailing current contact information to awards@naspa.us. The Bowl of Hygeia is on display in the APhA History Hall located in Washington, DC. FEBRUARY 2021
|
13
SAVE THE DATE! 131st ANNUAL MEETING AND CONVENTION July 7 – 11, 2021
You don’t want to miss this event! General Education Track Consultant Education Track Student & Technician Track Social Distanced Special Events Exhibits • Receptions • Awards
Sawgrass Marriott Golf Resort & Spa Ponte Vedra Beach, FL
Room reservations can be made by calling (888) 821-1364. Room Rates: $179 plus tax based on single/double occupancy. The room reservation deadline is Friday, June 11, 2021 or when room block is full. Thereafter, reservations may be taken on a space available or rate available basis. There is an optional resort fee. Self-parking is discounted to $10 per day. Please be sure to ask for the Florida Pharmacy Association group rate. All reservations must be accompanied by a first night room deposit or guaranteed with a major credit card. The check-in time is 4:00pm and the checkout time is 11:00 am. 14
|
FLORIDA PHARMACY TODAY
1
FPA 131st Annual Meeting and Convention July 7-11, 2021 Ponte Vedra Beach, FL
,
55Daily Education Registration
Participant Information Participant Information
Daily registration does not include admittance to functions or handbooks. Handouts will be posted on our website July 6.
Name: _____________________________________________________ Name _______________________________________________ Address______________________________________________ Badge Name: _______________________________________________ City, State, Zip_________________________________________ Mailing Address: ____________________________________________ Phone___ ________________________ City, State, Zip: _____________________________________________ Email________________________________________________ Phone: (W) (H)_______________________ Practice Setting________________________________________ License: PS______________ PU _____________RPT_________ Fax: ______________________________________________________ NABP Date of Birth___________ License:e-profile#__________________ PS________________ PU_________ Other State________ Emergency Contact Name/Number_________________________
2
Before
June 18
Onsite
Amount
FPA Member
$165
$185
$_______
Non Member
$215
$235
$_______
Member Technician
$65
$85
$_______
Non Member Technician
$90
$110
$_______
Handbooks
$40
$40
$_______
Please select the day(s) you will attend: Thursday
Full Package Registration
Full package registration includes Educational Programs Thursday-Sunday, House of Delegates on Thursday, Exhibit Hall Friday and Saturday, Receptions, and Awards Event on Saturday. Handbooks are not included in full package registration. Handouts will be available the week of the convention on our website, www.floridapharmacy.org. Onsite
Amount_
6
Friday
Saturday
Sunday
Additional Tickets
The following events are included in the Full Registration Package, if requested. However, you must purchase additional tickets for guests who are NOT registered. Quantity
Price
Amount
Exhibit Hall
$30
$______
Awards Event
$80
$______
2FPA Member
Before June 18 $345
$430
$_______
Non Member
$525
$610
$_______
Pharmacist BEST Value
$540
$625
$_______
Member Technician
$155
$185
$_______
Non Member Technician
$175
$210
$_______
Technician BEST Value
$185
$220
$_______
$150
$170
$_______
Poster Presenter
$40
$40
$_______
(Registration fee is based upon membership and professional status for Non-convention registrants.)
3Student
Handbooks
(BEST Value includes Registration & Membership)
3
House of Delegates (Thursday)
FPPC Reception (Thursday)
Exhibit Hall (Friday and/or Saturday)
Awards Event (Saturday)
Christian Fellowship (Sunday)
I will not attend any of these functions.
4
House of Delegates
House of Delegates (Non-convention registrants)
Special Events Registration
The Poster Event is available to all pharmacy professionals and included in full and daily registrations. The Student Awards Event is not included in any registration packages. Quantity
8
_______
Amount $______
$50
$______
FPA Polo Shirt (Deadline is June 4) Quantity Price
9
Price
One Day Registration
Student Awards Event
Please indicate below which functions you will attend. If no boxes are selected, we will assume you will not attend any of the events listed below. Please see box 6 for additional tickets.
7
Yes
______
Payment
$35
M/F ______
Size ______
Amount $_______
Total Enclosed: $______
Check (To: FPA) AMEX Discover MasterCard Visa Account # ____________________________________________ Security Code _________________ Expiration Date __________
Before June 8 $165
Amount ______
Billing Address ________________________________________ Signature ____________________________________________
Four Ways to Register
Mail: FPA, 610 North Adams Street, Tallahassee, FL 32301 Phone: 850-222-2400 Fax: 850-561-6758 Web: www.floridapharmacy.org
Schedule and Fee Subject to Change
FEBRUARY 2021
|
15
FPA Legislative Highlights — March By Adams St. Advocates
Priority Bills on the Move
Other Bills to Watch/Monitor
PBM Medicaid Carve Out SUPPORT/High Priority ■ HB 1043 – Waiting to be assigned to committees ■ SB 1306 – Waiting to be assigned to committees
Dispensing Medicinal Drugs ■ HB 29 – Waiting to be scheduled in the 1st committee, Professions & Public Health ■ SB 262 – Waiting to be scheduled in the 1st committee, Health Policy
Prescription Drug Coverage (PBM Enforcement) SUPPORT/Medium Priority ■ HB 1155 – Waiting to be assigned to committees ■ SB 390 – Waiting to be scheduled in Banking and Insurance Administration of Vaccines SUPPORT/Low Priority ■ HB 1063 – Waiting to be assigned to committees ■ SB 898 – Waiting to be scheduled in the 1st committee, Health Policy ■ SB 768 – Waiting to be scheduled in the 2nd committee, Children, Families & Elder Affairs Administration of Vaccines SUPPORT/Low Priority ■ HB 459 – Waiting to be scheduled in the 1st committee, Professions & Public Health ■ SB 494 – Passed its 1st committee, waiting to be scheduled in 2nd and final committee Rules Antiretroviral Drugs SUPPORT/Low Priority ■ HB 607 – Waiting to be assigned to committees ■ SB 928 – Waiting to be scheduled in the 1st committee, Health Policy Telehealth OPPOSE/Work to amend ■ HB xxx – no House bill filed yet ■ SB 700 – Passed Health Policy Committee
16
|
FLORIDA PHARMACY TODAY
Health Insurance Prior Authorization ■ HB 851 – Waiting to be assigned to committees ■ SB 528 – Waiting to be scheduled in the 1st committee, Banking and Insurance Step Therapy Protocols ■ HB 1001 – Waiting to be assigned to committees ■ SB 1290 – Waiting to be assigned to committees Prescription Insulin Drugs Nonopioid Alternatives ■ HB 725 – Waiting to be assigned to committees ■ SB 530 – Passed all committees and is on the Senate floor Prescription Insulin Drugs ■ HB 109 – Waiting to be scheduled in the 1st committee, Finance & Facilities ■ SB 786 – Waiting to be scheduled in the 1st committee, Banking & Insurance
24/7 coverage lets you focus on patients, not potential mistakes.
PROFESSIONAL LIABILITY COVERAGE COMPARISON PHARMACIST MUTUAL INSURANCE COMPANY
COMPETITOR
Pharmacists Professional Liability
$1MM per occurrence / $3MM aggregate $2MM per occurrence / $4MM aggregate
$1MM per occurrence / $3MM aggregate
Sterile Compounding
Available
?
Pharmacists License Defense Coverage
$250,000 per occurrence / $250,000 aggregate
$25,000
Board of Pharmacy Imposed Fees
$2,500 sublimit
?
HIPAA Claim Defense Coverage
$50,000
$25,000
Assault Coverage
$25,000
$25,000
Sexual and Physical Abuse Coverage
$50,000
$25,000 sublimit
$1,500 per day / $50,000 per occurrence
1,000 per day / $25,000 aggregate
$50,000 limit
$10,000 aggregate
Loss of Income Legal fees – Respond to Subpoena
Professional | Commercial | Personal | Life & Disability
phmic.com Policy terms and conditions control. Coverage may not be available in all states. Life and disability insurance are written through PMC Advantage Insurance Services, Inc., a wholly-owned subsidiary of Pharmacists Mutual Insurance Company.
WHAT IF you were named in a lawsuit and needed a lawyer?
WHAT IF your employer does not have the coverage to protect you?
WHAT IF you have a second job, volunteer, or give advice to a friend or neighbor? FEBRUARY 2021
|
17
C A L L
F O R
APhA Foundation and NASPA Bowl of Hygeia Awarded to a pharmacist for outstanding community service above and beyond professional duties. The use of the following selection criteria is required: ■ The recipient must be a Florida licensed pharmacist and a member of FPA. ■ ■ T recipient has not previously received the award. ■ two on its award committee or an officer of the association other than in an ex officio capacity. ■ has compiled an outstanding record of community service, which, apart from his/her specific identification as a pharmacist, reflects well on the profession. Beal and Powers Pharmacist of the Year Award Awarded to the “Pharmacist of the Year.” Criteria: ■ must be a Florida registered pharmacist and a member of the FPA. ■ has rendered outstanding service to pharmacy within the past five years. Technician of the Year Award Awarded annually to a Florida pharmacy technician who is recognized for his/her outstanding performance and achievement during his/her career. Criteria: ■ Candidate must be a member of the Florida Pharmacy Association for at least two years. ■ Candidate must have demonstrated contributions and dedication to the advancement of pharmacy technician practice.
18
|
FLORIDA PHARMACY TODAY
N O M I N A T I O N S ■ Candidate must have demonstrated
contributions to the Florida Pharmacy Association and/or other pharmacy organizations. ■ Candidate must have demonstrated commitment to community service. ■ Candidate is not a past recipient of this award. R.Q. Richards Award This award is based on outstanding achievement in the field of pharmaceutical public relations in Florida. Criteria: ■ recipient must be a Florida registered pharmacist and a member of the FPA. ■ has displayed outstanding achievement in the field of pharmaceutical public relations in Florida. Frank Toback/AZO Consultant Pharmacist Award Criteria: ■ Candidate must be an FPA member, registered with the Florida Board of Pharmacy as a consultant pharmacist in good standing. ■ Candidate should be selected based on their outstanding achievements in the field of consultant pharmacy. DCPA Sidney Simkowitz Pharmacy Involvement Award Presented annually to a Florida pharmacist who has been active at the local and state pharmacy association level in advancement of the profession of pharmacy in Florida. Criteria: ■ A minimum of five years of active involvement in and contributions to the local association and FPA. ■ Candidate must have held office at local level pharmacy association. ■ Member in good standing for a period of at least five years in the FPA and must have served as a member or chairman of a committee of the association.
F P A
■ Candidate must have been active-
ly involved in a project that has or could potentially be of benefit to members of the profession.
Pharmacists Mutual Companies Distinguished Young Pharmacist Award Awarded to a young pharmacist for their involvement and dedication to the practice of pharmacy. Criteria: ■ Licensed to practice for nine years or fewer. ■ Licensed to practice in the state in which selected. ■ Participation in national pharmacy association, professional programs, and/or community service. IPA Roman Maximo Corrons Inspiration & Motivation Award Interamerican Pharmacists Association created this award to honor the memory of Roman M. Corrons who inspired and motivated countless pharmacists to participate actively and aspire to take on leadership roles in their profession. Roman was always there with guidance and support that motivated pharmacists and encouraged visionary leadership, approachable active membership and succession planning. This award recognizes the motivators among us who inspire others to continue to advance the profession. Criteria: ■ The recipient must be a Florida Licensed Pharmacist and a member of the FPA. ■ Candidate should motivate others to excel within the profession by encouraging them to be leaders. ■ Candidate is not necessarily an association officer, but guides, supports and/or inspires others. A brief description on the candidate’s motivational/inspirational skills must accompany the nomination.
A W A R D S
2 0 2 0 - 2 0 2 1
The Jean Lamberti Mentorship Award The Jean Lamberti Mentorship Award was established in 1998 to honor those pharmacists who have taken time to share their knowledge and experience with pharmacist candidates. The award is named in honor of long time FPA member Jean Lamberti for her effort in working with pharmacy students. Criteria: ■ The recipient must be an FPA member. ■ The recipient must serve as a role model for the profession of pharmacy.
Upsher Smith Excellence in Innovation Award Awarded to honor practicing pharmacists who have demonstrated innovation in pharmacy practice that has resulted in improved patient care. Criteria: ■ The recipient has demonstrated innovative pharmacy practice resulting in improved patient care. ■ The recipient should be a practicing pharmacist within the geographic area represented by the presenting Association. Qualified Nominee: A pharmacist practicing within the geographic area represented by the presenting Association.
DEADLINE FOR NOMINATIONS: FEBRUARY 28, 2021 FPA AWARDS NOMINATION FORM I AM PLEASED TO SUBMIT THE FOLLOWING NOMINATION:
NOMINATED BY:
Name:
Name:
Address:
Date Submitted: Signature:
FOR THE FOLLOWING AWARD: APhA Foundation and NASPA Bowl of Hygeia Beal and Powers Pharmacist of the Year Award R.Q. Richards Award
Please describe briefly below the nominee's accomplishments, indicating why you feel he or she should receive this award. (Attach additional sheets if necessary.)
Frank Toback/AZO Consultant Pharmacist Award DCPA Sydney Simkowitz Award Pharmacists Mutual Co. Distinguished Young Pharmacist Award IPA Roman Maximo Corrons Inspiration & Motivation Award The Jean Lamberti Mentorship Award Upsher Smith Excellence in Innovation Award
MAIL NOMINATONS TO: Annual Awards, Florida Pharmacy Association, 610 N. Adams St., Tallahassee, FL 32301 (850) 222-2400 FAX (850) 561-6758 DEADLINE FOR NOMINATIONS IS FEBRUARY 28, 2021
FEBRUARY 2021
|
19
“I’M ALWAYS WATCHING OUT FOR MY PATIENTS, BUT WHO’S WATCHING OUT FOR ME?”
WE ARE. We are the Alliance for Patient Medication Safety (APMS), a federally listed Patient Safety Organization. Our Pharmacy Quality Commitment (PQC) program: • • • •
Helps you implement and maintain a continuous quality improvement program Offers federal protection for your patient safety data and your quality improvement work Assists with quality assurance requirements found in network contracts, Medicare Part D, and state regulations Provides tools, training and support to keep your pharmacy running efficiently and your patients safe
Call toll free (866) 365-7472 or visit www.pqc.net PQC IS BROUGHT TO YOU BY YOUR STATE PHARMACY ASSOCIATION
